For the period of 01 to 07 October 2022 Reviewed by: Department of Health (DOH) – Health Technology Assessment Division (HTAD) Document Link: 01 to 07 October 2022 Document Preview:
Evidence brief for 24 to 30 September 2022
For the period of 24 to 30 October 2022 Reviewed by: Department of Health (DOH) – Health Technology Assessment Division (HTAD) Document Link: 24– 30 September 2022 Document Preview:
HTAC Preliminary Recommendation on Abiraterone Acetate (250mg Tablet) and Enzalutamide (40mg Soft Gel Capsule)
Link to evidence summary Publication date: 04 October 2022 (Stakeholders may submit appeals to hta@doh.gov.ph until 18 October 2022 using the prescribe form found here: Topic Nomination ) Document Preview:
Evidence brief for 17 to 23 September 2022
For the period of 17 to 23 September 2022 Reviewed by: Department of Health (DOH) – Health Technology Assessment Division (HTAD) Document Link: 17– 23 September 2022 Document Preview: